Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2008 3
2009 3
2010 4
2011 1
2012 3
2013 4
2014 5
2015 7
2016 2
2017 2
2018 7
2019 3
2020 8
2021 14
2022 19
2023 18
2024 29
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.
Tursi A, Mocci G, Costa F, Ceccarelli L, Savarino E, De Barba C, Mucherino C, D'Antonio E, Montesano L, Marzo M, Scaldaferri F, Napolitano D, Pugliese D, Gravina AG, Pellegrino R, Spagnuolo R, Luzza F, Cuomo A, Donnarumma L, Maconi G, Cataletti G, Bertani L, Bodini G, Pasta A, Piergallini S, Serio M, Scarcelli A, Capone P, Cortellini F, Rodino S, Sebkova L, Vespere G, Sedda S, D'Onofrio V, De Luca L, Gaiani F, Kayali S, Pagnini C, Graziani MG, Di Paolo MC, Allegretta L, Cazzato AI, Scorza S, Ferronato A, Ribaldone DG, Aragona G, Perazzo P, Forti G, Di Fonzo M, Iacopini F, Pica R, Cassieri C, Onidi FM, Usai Satta P, Elisei W, Picchio M, Papa A. Tursi A, et al. Among authors: gravina ag. Intest Res. 2025 Sep 29. doi: 10.5217/ir.2025.00067. Online ahead of print. Intest Res. 2025. PMID: 41017298 Free article.
Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora Study.
Conti Bellocchi MC, Cattani Mottes M, Blesl A, Cremer A, Festa S, Uzzan M, Cúrdia Gonçalves T, Rispo A, Viganò C, Koutroubakis I, Gravina AG, Pugliese D, Eder P, Vieujean S, Fantini MC, Yzet C, Argyriou K, Pouillon L, Ribaldone DG, Michielan A, Truyens M, Viola A, Savarino EV, Ellul P, Gisbert JP, Spyridon V, Campigotto M, Oliveira R, Variola A, Loy L, Pukitis A, Fragaki M, Guarino AD, Mantaka A, Ramos L, Crinò SF, Ciccocioppo R, Frulloni L, Pandora Study Group. Conti Bellocchi MC, et al. Among authors: gravina ag. Medicina (Kaunas). 2025 Aug 26;61(9):1532. doi: 10.3390/medicina61091532. Medicina (Kaunas). 2025. PMID: 41010923 Free PMC article.
Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.
Belli V, Sforza V, Cardone C, Martinelli E, Barra G, Matrone N, Napolitano S, Morgillo F, Tuccillo C, Federico A, Dallio M, Loguercio C, Gravina AG, Palma R, Ciardiello F, Troiani T. Belli V, et al. Among authors: gravina ag. Oncotarget. 2025 Aug 29;16:679. doi: 10.18632/oncotarget.28765. Oncotarget. 2025. PMID: 40879681 Free PMC article. No abstract available.
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis-Associated Spondyloarthropathy: a multicenter prospective study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).
Macaluso FS, Grova M, Bossa F, Carparelli S, Pugliese D, Cuccia G, Cappello M, Muscarella S, Saibeni S, Bezzio C, Armuzzi A, Gravina AG, Pellegrino R, Andrea Caprioli F, Sorge A, Soriano A, Ribaldone DG, Festa S, Variola A, Ferracane C, Onali S, Fantini MC, Orlando A. Macaluso FS, et al. Among authors: gravina ag. Therap Adv Gastroenterol. 2025 Aug 25;18:17562848251367559. doi: 10.1177/17562848251367559. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40873656 Free PMC article.
140 results